Abeona Therapeutics (ABEO) Non Operating Income (2011 - 2026)

Abeona Therapeutics' Non Operating Income history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.

• On a quarterly basis, Non Operating Income fell 64.54% year-over-year to $50000.0 in Q1 2026; TTM through Mar 2026 was $319000.0, a 72.8% decrease from a year earlier, with the FY2025 full-year figure at $410000.0, down 65.66% from the prior year.
• Non Operating Income eased to $50000.0 in Q1 2026 per ABEO's latest filing, from $51000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $2.2 million in Q2 2023 and bottomed at -$118000.0 in Q2 2022.
• The 5-year median for Non Operating Income is $143000.0 (2024), against an average of $296062.5.
• Across the five-year window, Non Operating Income jumped 1977.12% in 2023 and tumbled 92.31% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $277000.0 in 2022, then fell by 22.74% to $214000.0 in 2023, then soared by 209.81% to $663000.0 in 2024, then tumbled by 92.31% to $51000.0 in 2025, then declined by 1.96% to $50000.0 in 2026.
• Per Business Quant, the three latest ABEO Non Operating Income figures stand at $50000.0 (Q1 2026), $51000.0 (Q4 2025), and $129000.0 (Q3 2025).